Sign in
CAI Stock Price, Chart, Stats & News
Caris Life Sciences, Inc.
Save
Caris Life Sciences, Inc. (CAI) does not currently pay a dividend.
4.94B
Market cap
–
Current P/E
44.64x
Forward P/E
CAI chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 66.40% |
Operating margin | 5.56% |
Pretax margin | -8.38% |
Net margin | -8.39% |
Effective tax rate | – |
ROA | -6.05% |
ROE | 24.96% |
D/E | 0.66x |
Interest coverage ratio | 0.96x |
CAI valuation
P/E | – |
P/S | 5.90x |
P/B | 49.09x |
P/CF | 546.95x |
P/FCF | 145.73x |
P/OCF | 546.95x |
PEG | -16.84x |
EV multiple | 1238.95x |
About
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of molecular diagnostic offerings includes MI Profile, a specialized solution analyzing tissue samples, and Caris Assure, a blood-based test designed for cancer treatment applications.
Similar securities
Based on sector and market capitalization
Report issue